Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care.

Our Team

Karuna Therapeutics is bringing together a community of scientists, clinicians, and leaders with deep expertise in neuroscience and drug development.

Steve Paul, M.D.

Chairman of the Board, President and Chief Executive Officer

Stephen Brannan, M.D.

Chief Medical Officer

Andrew Miller, Ph.D.

Founder and Chief Operating Officer

Troy A. Ignelzi

Chief Financial Officer

Giorgio Attardo, Ph.D.

Vice President, CMC and Preclinical Development

Jim Audia, Ph.D.

Head of Medicinal Chemistry and Senior Adviser

Gregory T. Brophy, Ph.D.

Head of Regulatory and Senior Adviser

Jason Brown

Vice President, Corporate Finance

Christian Felder, Ph.D.

Vice President, Discovery Research

Inder Kaul, M.D., MPH

Vice President, Clinical Development

Mia Kelley, J.D.

Vice President, Legal Affairs

Jim Monn, Ph.D.

Vice President, Medicinal Chemistry

Stephanie Moore

Vice President, Human Resources

Sharon Sawchak, R.N.

Vice President, Clinical Operations and Compliance

Gregg A. Pratt, Ph.D

Vice President, Regulatory Affairs

Andrew Parratt

Vice President, Commercial Planning & Operations

Peter Weiden, M.D.

Vice President, Medical

Board of Directors

Steve Paul, M.D.

Chairman of the Board, President and Chief Executive Officer

Christopher J. Coughlin

Former Advisor to the Chairman and CEO & Executive Vice president and Chief Financial Officer, Tyco International Ltd.

Jim Healy, M.D., Ph.D.

General Partner, Sofinnova Investments

Jeff Jonas, M.D.

Chief Executive Officer, Sage Therapeutics

Robert Nelsen, MBA

Co-Founder and Managing Director, Arch Venture Partners

Laurie Olson

Former Executive Vice President of Strategy and Commercial Operations at Pfizer Inc.

Atul Pande, M.D.

Former Senior Vice President, Head of Neuroscience and Senior Advisor, Pharmaceutical R&D at GlaxoSmithKline; Member, Karuna Therapeutics Scientific Advisory Board

Heather Preston, M.D.

Managing Partner, Pivotal bioVenture Partners

Denice Torres

CEO of The Ignited Company, Founder of The Mentoring Place, former Chief Strategy and Business Transformation Officer, Medical Device, Johnson & Johnson

David Wheadon, M.D.

Former SVP, Global Regulatory Affairs, Patient Safety and Quality Assurance, AstraZeneca Pharmaceuticals

Scientific Advisory Board

Alan Breier, M.D.

Chief Clinical Advisor & Chair, Karuna Scientific Advisory Board; Senior Professor of Psychiatry, Indiana University Mental Health Research and Education; Vice-Chair for Clinical Research; Chief, IU Psychotic Disorders Program; Director, Prevention and Recovery Center (PARC), Indiana University School of Medicine

Edmund Harrigan, M.D.

Former SVP, Worldwide Safety & Regulatory, Pfizer, Inc.

Richard Keefe, Ph.D.

Professor of Psychiatry, Psychology, and Neurosciences, Duke University Medical Center

Allan Levey, M.D., Ph.D.

Professor & Chair, Department of Neurology at Emory University; Director, Goizueta Alzheimer’s Disease Research Center

Jeffrey Lieberman, M.D.

Lawrence C. Kolb Professor and Chairman, Department of Psychiatry, Columbia University College of Physicians and Surgeons; Director, New York State Psychiatric Institute; Psychiatrist-in-Chief of the New York-Presbyterian Hospital – Columbia University Medical Center.

Atul Pande, M.D.

Former Senior Vice President, Head of Neuroscience and Senior Advisor, Pharmaceutical R&D at GlaxoSmithKline; Board Member, Karuna Therapeutics

William Z. Potter, M.D., Ph.D.

Former VP, Translational Neuroscience, Merck; Former Head of Early Clinical Development, Eli Lilly

Anantha Shekhar, M.D., Ph.D.

Director, Indiana Clinical & Translational Sciences Institute; Distinguished Professor of Psychiatry, of Neurobiology and of Pharmacology & Toxicology;  August M. Watanabe Professor of Medical Research, and Executive Associate Dean for Research Affairs at the Indiana University School of Medicine

Carol A. Tamminga, M.D.

Lou and Ellen McGinley Distinguished Chair and the McKenzie Chair in Psychiatry at the University of Texas Southwestern Medical School; Chairman of the Department of Psychiatry; Chief of the Translational Neuroscience Division in Schizophrenia at UT Southwestern